Deciphera Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 42 U.S.-traded ETFs. DCPH has around 3.7M shares in the U.S. ETF market. The largest ETF holder of DCPH is the SPDR S&P Biotech ETF (XBI), with approximately 1.05M shares. Investors may also find of interest that the ETF with the largest allocation to DCPH stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 2.20%. On average, U.S. ETFs allocate 0.22% of DCPH to their portfolios.
Additionally, DCPH is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with DCPH as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.59%.